← Cash Liquidation Value Rankings
Cash Liquidation Value — Pharmaceuticals
Rankings as of 2025-12-31
Last updated: 2026-04-13 04:47 UTC
| Rank | Ticker | Company | Value | Period |
|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Inc | $-917.40M | 2025-12-31 |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | $-4.22B | 2025-12-31 |
| 3 | ABT | Abbott Laboratories | $-22.11B | 2025-12-31 |
| 4 | MRK | Merck & Co., Inc. | $-61.71B | 2025-12-31 |
| 5 | LLY | Eli Lilly and Company | $-70.19B | 2025-12-31 |
| 6 | JNJ | Johnson & Johnson | $-75.25B | 2025-12-28 |
| 7 | PFE | Pfizer Inc | $-100.10B | 2025-12-31 |
| 8 | ABBV | Abbvie Inc. | $-103.49B | 2025-12-31 |